1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

MESO TV | eVOLVE Meso Clinical Trial

On this episode of MesoTV, join our Patient Services Director, Julie White, as she speaks with Marjorie Zauderer, MD, MS, FACP, and Lee Krug, MD, about the eVOLVE meso clinical trial for patients with pleural mesothelioma. Our SponsorsMesoTV is a program by the Mesothelioma Applied Research Foundation. This program is made…

Pleural Surgery

Surgery is vital option for treatment for many patients with pleural mesothelioma. This session discusses how pleural surgery works and why it is an option for some patients. This session is presented by:Chuong Hoang, MD, National Cancer Institute This is a recording of a session at the 2024 International Symposium on…

mesothelioma research

FDA Approves KEYTRUDA® (pembrolizumab) Plus Pemetrexed and Platinum Chemotherapy as First-Line Treatment for Patients with Unresectable or Metastatic Malignant Pleural Mesothelioma

For patients with MPM (Malignant Pleural Mesothelioma), the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) as a first-line treatment when combined with pemetrexed and platinum-based chemotherapy. Keytruda(pembrolizumab) is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body’s immune system to help…